SG Americas Securities LLC cut its stake in shares of Concentrix Corporation (NASDAQ:CNXC - Free Report) by 68.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,981 shares of the company's stock after selling 38,835 shares during the quarter. SG Americas Securities LLC's holdings in Concentrix were worth $748,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its position in Concentrix by 3.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,176 shares of the company's stock valued at $8,730,000 after purchasing an additional 5,771 shares during the last quarter. Allworth Financial LP raised its holdings in Concentrix by 90.6% in the third quarter. Allworth Financial LP now owns 856 shares of the company's stock worth $40,000 after buying an additional 407 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in shares of Concentrix by 7.1% in the third quarter. CANADA LIFE ASSURANCE Co now owns 36,884 shares of the company's stock worth $1,763,000 after buying an additional 2,437 shares in the last quarter. XTX Topco Ltd purchased a new stake in shares of Concentrix during the third quarter valued at approximately $890,000. Finally, Susquehanna Fundamental Investments LLC grew its holdings in shares of Concentrix by 4.4% during the third quarter. Susquehanna Fundamental Investments LLC now owns 95,502 shares of the company's stock valued at $4,407,000 after buying an additional 3,988 shares during the last quarter. Hedge funds and other institutional investors own 90.34% of the company's stock.
Concentrix News Roundup
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: CFO insider purchase: Concentrix CFO Andre Valentine bought 2,500 shares at ~$27.95, increasing his stake to 89,066 shares — a signal of management confidence that can support the stock. Insider Buying: Concentrix NASDAQ: CNXC CFO Purchases 2,500 Shares of Stock
- Positive Sentiment: Dividend & institutional accumulation: The company declared a $0.36 quarterly dividend (5.1% yield) and several large institutional managers increased positions, which supports demand and provides an income floor for investors. Concentrix stock — MarketBeat
- Neutral Sentiment: Short-interest data shows no meaningful change or signal (reported zero shares / 0.0 days), a likely data artifact and not a driver of liquidity or squeeze risk today.
- Negative Sentiment: Mixed / slightly conservative quarterly guidance: Q2 FY26 EPS guidance of $2.57–2.69 vs. a $2.67 consensus — the range’s midpoint is slightly below consensus, creating uncertainty around near-term performance and pressuring the stock.
- Negative Sentiment: Analyst price-target cut: A recent downgrade to a $47.12 price target (an ~18.6% reduction) is a clear negative catalyst that likely weighed on investor sentiment. Concentrix (CNXC) price target decreased by 18.59% to 47.12
- Negative Sentiment: Margin and leverage concerns: Market commentary highlights high debt and pressured margins (alongside a recent slight quarterly EPS miss), which increases execution risk and likely contributed to downward pressure.
Concentrix Stock Down 8.4%
CNXC opened at $26.12 on Friday. The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of -1.21, a PEG ratio of 0.36 and a beta of 0.50. The firm has a 50 day moving average price of $31.67 and a 200-day moving average price of $38.05. Concentrix Corporation has a twelve month low of $24.27 and a twelve month high of $62.14. The company has a quick ratio of 1.40, a current ratio of 1.18 and a debt-to-equity ratio of 1.43.
Concentrix (NASDAQ:CNXC - Get Free Report) last issued its earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.65 by ($0.04). The company had revenue of $2.50 billion during the quarter, compared to analysts' expectations of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.79 EPS. Equities research analysts forecast that Concentrix Corporation will post 10.11 earnings per share for the current year.
Concentrix Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 5th. Investors of record on Friday, April 24th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Friday, April 24th. This represents a $1.44 annualized dividend and a dividend yield of 5.5%. Concentrix's payout ratio is presently -6.68%.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on CNXC shares. Wall Street Zen lowered shares of Concentrix from a "buy" rating to a "hold" rating in a report on Saturday, March 28th. Robert W. Baird reduced their target price on Concentrix from $52.00 to $40.00 and set an "outperform" rating for the company in a report on Wednesday, March 25th. Barrington Research decreased their price target on Concentrix from $62.00 to $38.00 and set an "outperform" rating for the company in a research note on Wednesday, March 25th. Canaccord Genuity Group lowered their price target on Concentrix from $80.00 to $55.00 and set a "buy" rating on the stock in a report on Wednesday, March 25th. Finally, Weiss Ratings cut Concentrix from a "hold (c-)" rating to a "sell (d)" rating in a research report on Thursday, January 29th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Concentrix has a consensus rating of "Hold" and a consensus price target of $48.50.
Get Our Latest Stock Analysis on CNXC
Insiders Place Their Bets
In other news, CFO Andre S. Valentine purchased 2,500 shares of the business's stock in a transaction on Thursday, April 9th. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the purchase, the chief financial officer directly owned 89,066 shares in the company, valued at $2,489,394.70. This trade represents a 2.89% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Christopher A. Caldwell purchased 1,000 shares of the business's stock in a transaction on Thursday, January 29th. The shares were purchased at an average price of $37.07 per share, with a total value of $37,070.00. Following the completion of the purchase, the chief executive officer owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.90% of the stock is currently owned by corporate insiders.
Concentrix Profile
(
Free Report)
Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Read More
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report